CasNo.114870-03-0,CAS:114870-03-0 Fondaparinux sodium 99,(114870-03-0) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: 99.5%
Payment Terms : T/T,Other

Keywords

Fondaparinux sodium Fondaparinux sodium high purity Fondaparin sodium

Quick Details

Appearance:White powder
Application:Pharmaceutical
PackAge:according to customers' requirements
ProductionCapacity:100|Metric Ton|Year
Storage:store in cool and dry
Transportation:by sea or by air

Superiority:

Top quality USP39 Fondaparinux sodium CAS:114870-03-0 with best price.

Product name	Fondaparinux sodium
Appearance	White to off-white solid
EINECS	N/A
MF	C31H43N3Na10O49S8
MW	1728.08
Assay	95%~103%

Product: Name	Fondaparinux sodium; Arixtra; Fondaparin Sodium; IC 85158; IC 851589; Org 31540; SR 90107A; Xantidar; SR-90107;Org-31540;SR-90107A;Quixidar
CAS No.:	114870-03-0
Chemical Name:	Methyl O-2-Deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-β- D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-α-D-glucopyranoside 6-(Hydrogen Sulfate) Decasodium Salt; O-[2-Deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl]-(1--4)-O-(beta-D-glucopyranurosonyl)-(1--4)-O-[2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl]-(1--4)-O-(2-O-sulfo-alpha-L-idopyranurosonyl)-(1--4)-O-[2-deoxy-1-O-methyl-6-O-sulfo-2
Structure
Molecular Formula	C31H43N3Na10O49S8		Molecular Weight	1728.08
Items		Specifications		Results
Appearance		White or off-white solid		White solid
Identification		H-NMR: Should conform to the standard		Complies
Water		NMT5.0%		0.5%
Residual solvents		Pyridine: NMT200ppm		N.D.
		Ethyl alcohol: NMT5000ppm		N.D.
Related substances		Any single impurity: NMT1.0%		0.7%
		Total impurities: NMT2.0%		1.8%
Heavy metals		NMT30ppm		Complies
Assay:		95.0 to 102.0%		98.5%
Purity (HPLC)		NLT 98.0%		98.2%

Applications: Synthetic pentasaccharide corresponding to the anti-thrombin binding site of heparin. Anti-thrombotic.

Fondaparinux (Arixtra) is an anticoagulant medication.Fondaparinux sodium is a synthetic and specific inhibitor of activated Factor X (Xa).

Details:

Kono Chem Co.,Ltd is a leading producer of standardized herbal extracts, natural active ingredients and APIs for pharmaceutical, health food and cosmetic industries.

The botanical raw materials are subject to strict selection and inspection, and extracts are manufactured according to methods developed by Pioneer. They include inspections to guarantee a high quality standard from both analytico-chemical and therapeutic points of view, and take into consideration the state of art in different fields: research and development, analyses, processes and machinery, therapeutic applications on a scientific basis.

With our phytopharmaceutical background and knowledge through experience, PIONEER can also provide a wide range of analytical services and reference substances to our clients. In addition, We also manufacture pharmaceutical raw materials of nucleotide species, mainly including as below: SAM-e Tosylate Disulfate; SAM-e 1,4-Butanedisulfonate; Polycytidylic Acid; Polyinosinic Acid; Adenosine Triphosphate Disodium; and Cytidine Triphosphate Disodium; these items are our strongest advantage in China. Meanwhile, we can do custom made pharmaceutical ingredients depending on our professional experts in the pharmaceutical and chemistry industry.

Recently, Kono Chem has been working hard on the research and development of new cardiovascular and anesthesia drugs, we have got good achievements; moreover, we also offer natural anticancer drugs and other pharmaceutical intermediates. As a GMP standardized manufacturer, our products can meet or even exceed the standards of CP2010, USP32, BP2005 and EP4. Presently, 80% and above of our products have been well-recognized in dozens of countries and regions, such as USA, EU, South America and Southeast Asia. There are experienced technicians working for our institutes now, all of them are skilled. Pioneer is looking forward to cooperating with friends all over the world for getting collaborative development; we are willing to work with you to develop new drugs and expand new business, let's work together for bright future.